Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
7.24
+0.90 (14.20%)
At close: Jul 17, 2025

Sumitomo Pharma Company Description

Sumitomo Pharma Co., Ltd. engages in manufacture, and purchase and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.

The company offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia.

It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic.

Further, the company offers veterinary drugs, medical devices, etc. It has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022.

The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

Sumitomo Pharma Co., Ltd.
CountryJapan
Founded1897
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees3,832
CEOToru Kimura

Contact Details

Address:
6-8, Doshomachi 2-chome
Osaka, 541-0045
Japan
Phone81 6 6203 5321
Websitesumitomo-pharma.com

Stock Details

Ticker SymbolDNPUF
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3495000006
SIC Code2834

Key Executives

NamePosition
Hiroshi NomuraChief Executive Officer, President and Representative Director
Toru Kimura Ph.D.Senior Mngg Executive Off. of Glo. Crprate Stgy, F&A, Regen and Cell Med. Off., Kobe Ctr, Mfg. Plt and Dir.
Hiroyuki BabaMngg Executive Officer of Global Data Design, Lgl Affairs. IP, IT Mgt, and Frontier Business Off. & Director
Naoki NoguchiExecutive Officer of Corporate Governance and Communications, Vice President and Head of Corporate Communications
Takuya TaguchiM.E.O. of Sales and Marketing Div., SVice President, Hd of Sales & Marketing Div. and Dep. Hd of Japan Business Unit
Atsuko HiguchiManaging Executive Officer of External Affairs, Corporate Secretariat and Human Resources
Yoshiharu Ikeda Ph.D.Managing Executive Officer of Drug Research Division, Head of Japan Business Unit and Director
Koichi KozukiE.O. of R. Aff., Med. Sci., C.R.C. and Q.A., Senior Vice President, Hd of C.R.C. & Q.A. Div and Dp. Hd of Japan Business
Dr. Shigeyuki Nishinaka Ph.D.Managing Executive Officer of Business Development and Management and Director
Isao ShimizuExecutive Officer, Senior Vice President, Head of Drug Research Division and Senior Executive Research Director